氨基酸前体蛋白介导调节成年出生神经元的基础的分子通路
Haidong Hu1,2, Huidong Li2, Yu Chen2
1School of Life Sciences, Guangzhou University, Guangzhou, Guangdong Province, China.
Neural regeneration research
|November 27, 2025
概括
粉样蛋白前体蛋白 (APP) 缺乏影响阿尔茨海默氏症模型中的成年出生神经元. APP对于神经元的成熟至关重要,其缺失导致激发毒性和细胞死亡.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 阿尔茨海默氏病 (AD) 病原发生涉及来自粉样蛋白前体蛋白 (APP) 裂变的粉样β (Aβ) .
- 神经元损失是阿尔茨海默病的标志,但APP在成人神经发生和神经元功能中的作用尚不清楚.
研究的目的:
- 调查APP缺乏对成年出生颗粒细胞 (ABGCs) 和其生存的电生理学影响.
- 在AD小鼠模型中阐明APP在ABGCs成熟和兴奋性中的作用.
主要方法:
- 在App淘汰赛 (App-/-) 小鼠中使用了全细胞补丁录音.
- 复原病毒标签和免疫光染色确定并分析了ABGCs.
- 评估了电生理学特性,树突形态,突触传播和细胞存活率.
主要成果:
- APP缺陷最初增加了ABGC数量,但没有改变它们的早期兴奋性.
- 在以后的时间点,ABGCs表现出刺激性增加,形态异常,突触传输改变,KCC2表达减少.
- 在App-/-小鼠中,成熟神经元表现出激发能力下降,KCC2表达减少和亡增加.
结论:
- APP对于成年出生颗粒细胞的适当成熟至关重要.
- 在AD模型中,APP缺乏导致ABGCs中的兴奋毒性,导致成熟的神经元亡和潜在的认知缺陷.
相关概念视频
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


